Fondazione Telethon
Sean Russell is a Managing Partner at PrimeRA Pharma Partners, delivering regulatory affairs and biotech leadership to the advanced therapies ecosystem. Sean also serves as the Head of Regulatory Affairs at Fondazione Telethon and holds various leadership positions at Achilles Therapeutics plc. With a background in chemistry, Sean has extensive experience in regulatory affairs within the pharmaceutical industry. Additionally, Sean has been actively involved in the regulatory community, contributing to the organization and coordination of courses in the field.
This person is not in any offices
Fondazione Telethon
Founded in 1990, Telethon Italy is one of the biggest biomedical charity in Italy, whose mission is to advance biomedical research towards the diagnosis, cure and prevention of muscular dystrophies and other human genetic diseases. Telethon Italy focuses on scientific research and does not offer healthcare, material assistance to patients and families or advocacy. Since 1991, Telethon Italy has invested 394 million Euros in research and funded 2,477 research projects on more than 445 human genetic diseases, which range from basic research to clinical trials.